Morgan Stanley sets $32.81 price target for RxSight with Overweight rating By Investing.com – Canada Boosts
© Reuters. NEW YORK – Morgan Stanley has lately initiated protection on the medical machine firm RxSight (NASDAQ:RXST), assigning an Chubby advice and establishing a value goal of $32.81. This goal suggests a possible upside of 11.37% from the corporate’s final closing value of $29.46. Institutional traders have proven a robust perception within the prospects…